Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Triamtérène")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 392

  • Page / 16
Export

Selection :

  • and

Direct determination of triamterene by potentiometry using a coated wire selective electrodeARVAND, M; MOUSAVI, M. F; ZANJANCHI, M. A et al.Journal of pharmaceutical and biomedical analysis. 2003, Vol 33, Num 5, pp 975-982, issn 0731-7085, 8 p.Article

UEBER DIE DIURETISCHE UND SALURETISCHE AKTIVITAET VON P-HYDROXYTRIAMTEREN UND METHOXYTRIAMTEREN = L'ACTIVITE DIURETIQUE ET SALURETIQUE DU P-HYDROXYTRIAMTERENE ET DU METHOXYTRIAMTERENEVOLLMER G; MUTSCHLER E; VOELGER KD et al.1981; ARZNEIM.-FORSCH.; ISSN 0004-4172; DEU; DA. 1981; VOL. 31; NO 3; PP. 529-530; ABS. ENG; BIBL. 9 REF.Article

Hyponatraemia induced by a combination of hydrochlorothiazide and triamtereneROBERTS, C. J. C; CHANNER, K. S; BUNGAY, D et al.British medical journal (1857). 1984, Vol 288, Num 6435, issn 0007-1447, 1962Article

Liquid chromatographic analysis of triamterene and its major metabolite, hydroxytriamterene sulfate, in blood, plasma, and urineSORGEL, F; LIN, E. T; HASEGAWA, J et al.Journal of pharmaceutical sciences. 1984, Vol 73, Num 6, pp 831-833, issn 0022-3549Article

VERGLEICH DER KARDIALEN WIRKUNG VON TRIAMTEREN UND DESSEN PHASE-II-METABOLITEN P-HYDROXYTRIAMTERENSCHWEFELSAEUREESTER = COMPARAISON DE L'ACTIVITE CARDIAQUE DU TRIAMTERENE ET DE SON METABOLITE EN PHASE II L'ESTER SULFURIQUE DU P-HYDROXYTRIAMTERENEGREEF K; SCHUHMACHER P.1979; ARZNEIMITTEL-FORSCH.; DEU; DA. 1979; VOL. 29; NO 4; PP. 705-706; ABS. ENG; BIBL. 6 REF.Article

Evidence for an acute anti-magnesiuretic effect of triamterene derivativesPRIEWER, H; KRAFT, H; MUTSCHLER, E et al.Pharmaceutical research. 1985, Num 2, pp 90-93, issn 0724-8741Article

Liquid membrane phenomenon in diureticsBHISE, S. B; BHATTACHARJEE, D; SRIVASTAVA, R. C et al.Journal of pharmaceutical sciences. 1984, Vol 73, Num 11, pp 1579-1581, issn 0022-3549Article

EFFECTS OF TRIAMTERENE AND ITS PHASE 1 AND PHASE II METABOLITES ON SODIUM TRANSPORT OF THE ISOLATED FROG SKINKRAMER HJ; ROERIG M; VOELGER KD et al.1981; PHARMACOLOGY; ISSN 0031-7012; CHE; DA. 1981; VOL. 23; NO 3; PP. 149-155; BIBL. 19 REF.Article

HIGH-PERFORMANCE LIQUID CHROMATOGRAPHIC ANALYSIS OF TRIAMTERENE AND P-HYDROXYTRIAMTERENE IN PLASMAYAKATAN GJ; CRUZ JE.1981; J. PHARM. SCI.; ISSN 0022-3549; USA; DA. 1981; VOL. 70; NO 8; PP. 949-951; BIBL. 8 REF.Article

LE PTEROFENE DANS LE TRAITEMENT DE LA MALADIE HYPERTENSIVEKASALITSA CH L.1976; KLIN. MED.; S.S.S.R.; DA. 1976; VOL. 54; NO 1; PP. 33-36; ABS. ANGL.; BIBL. 1/2 P.Article

The effect of topical 0.5% triamterene suspension on the intraocular pressure of open angle glaucoma patients. A single dose studyMILLS, K. B; GILBERT, D. J; RIDGWAY, A. E. A et al.Current eye research (Print). 1984, Vol 3, Num 2, pp 273-277, issn 0271-3683Article

THE EFFECT OF SPIRONOLACTONE AND TRIAMTERENE ON INTRAOCULAR PRESSURE: A NEGATIVE REPORT = EFFET DU SPIRONOLACTONE ET DU TRIAMTERENE SUR LA PRESSION INTRAOCULAIRE: COMPTE RENDU NEGATIFSCHWARTZ DE.1974; ANN. OPHTHALMOL.; U.S.A.; DA. 1974; VOL. 6; NO 2; PP. 105-108; BIBL. 20REF.Article

Triamterene-induced crystalluria and cylinduria: clinical and experimental studiesFAIRLEY, K. F; WOO, K. T; BIRCH, D. F et al.Clinical nephrology. 1986, Vol 26, Num 4, pp 169-173, issn 0301-0430Article

ETUDE DE L'ACTION ANTI-HYPERTENSIVE DU TRIAMTERENE EN PRESCRIPTION ISOLEECONTE JJ; MAURETTE MH; FOURNIE GJ et al.1975; REV. MED. TOULOUSE; FR.; DA. 1975; VOL. 11; NO 3; PP. 197-203; ABS. ANGL. ESP.; BIBL. 14 REF.Article

ZUR ALTERSABHAENGIGKEIT DER PHARMAKOKINETIK VON TRIAMTEREN = DEPENDANCE PAR RAPPORT A L'AGE DE LA PHARMACOCINETIQUE DU TRIAMTERENESTOPP M; BRAEUNLICH H.1973; ACTA BIOL. MED. GERM.; ALLEM.; DA. 1973; VOL. 30; NO 1; PP. 121-132; ABS. ANGL.; BIBL. 19REF.Serial Issue

Bioavailability study of triamterene and xipamide using urinary pharmacokinetic data following single oral dose of each drug or their combinationMAHER, Hadir M; YOUSSEF, Rasha M; EL-KIMARY, Eman I et al.Journal of pharmaceutical and biomedical analysis. 2012, Vol 61, pp 78-85, issn 0731-7085, 8 p.Article

Triamterene Crystalline NephropathyNASR, Samih H; MILLINER, Dawn S; WOOLDRIDGE, Thomas D et al.American journal of kidney diseases. 2014, Vol 63, Num 1, pp 148-152, issn 0272-6386, 5 p.Article

Dissociation of the natriuretic and antikaliuretic properties of triamterene derivatives by dose-response experimentsPRIEWER, H; WOLF, E; KRAFT, H et al.Pharmaceutical research. 1987, Vol 4, Num 1, pp 66-69, issn 0724-8741Article

Antiarrhythmic properties of benzyl-triamterene derivatives in the coronary artery ligated and reperfused ratBUSCH, A. E; NETZER, T; ULLRICH, F et al.Arzneimittel-Forschung. 1991, Vol 41, Num 2, pp 125-127, issn 0004-4172, 3 p.Article

TRIAMTERENE-INDUCED PANCYTOPAENIA IN IDIOPATHIC HAEMOCHROMATOSISGOLDMANN M; ZEGERS DE BEYL D; DELWICHE F et al.1980; ACTA CLIN. BELG.; ISSN 0001-5512; BEL; DA. 1980; VOL. 35; NO 4; PP. 265-266; BIBL. 5 REF.Article

EFFECTS OF XIPAMIDE AND TRIAMTERENE-ALONE OR IN COMBINATION-ON ELECTROLYTE EXCRETION IN THE RATHOHENEGGER M; HOLZER F.1976; INTERNATION. J. CLIN. PHARMACOL. BIOPHARM.; GERM.; DA. 1976; VOL. 13; NO 4; PP. 298-303; BIBL. 11 REF.Article

Investigations on the magnesium retaining properties of triamterene derivatives with an aromatic side chainULLRICH, F; PRIEWER, H; KLEINSORGE, D et al.Magnesium-Bulletin. 1991, Vol 13, Num 1, pp 30-33, issn 0172-908X, 4 p.Article

Triamterene and renal stone formation the influence of tri-amterene and triamterene stones on calcium oxalate crystallizationWHITE, D. J; NANCOLLAS, G. H.Calcified tissue international. 1987, Vol 40, Num 2, pp 79-84, issn 0171-967XArticle

Bioavailability of a modified formulation capsule containing 25 MG hydrochlorothiazide and 50 MG triamtereneRANDOLPH, W. C; BEG, M. M. A; SWAGZDIS, J. E et al.Current therapeutic research. 1985, Vol 38, Num 6, pp 990-996, issn 0011-393XArticle

Oral triamterene dispositionSORGEL, F; HASEGAWA, J; LIN, E. T et al.Clinical pharmacology and therapeutics. 1985, Vol 38, Num 3, pp 306-312, issn 0009-9236Article

  • Page / 16